Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Interpublic Group’s Deutsch and Pfizer are splitting because they cannot come to terms on a new contract, said Val DiFebo, managing partner and director of client services.
“It really came down to contractual terms that really are inconsistent with the way we do business,” said DiFebo, adding, “This was just something we couldn’t work out.”
It is unclear what will happen with the brands that Deutsch handles: allergy medication Zyrtec, anti-depressant Zoloft and Bextra, an anti-inflammatory drug for arthritis patients.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in